How is everyone not talking about this paper?

It's about a superantigen insert in the spike of SARS-2 that isn't in the spike of SARS.

Jessica Rose

This Substack is about another danger associated with the spike protein, and not just the viral spike. This danger is called a superantigen. A superantigen can activate all sorts of T cells non-specifically to induce hyperinflammation and cytokine storms, for example.

A beautiful paper is currently uploaded to the pre-print server OSF PREPRINTS (submitted in November 2021) entitled: “Differences in Vaccine and SARS-CoV-2 Replication Derived mRNA: Implications for Cell Biology and Future Disease”.1 This paper looks at the differences between SARS-nCoV-2 viral spike and the modified mRNA injection spike and asks the question: is the modified spike as, even more pathogenic, than the SARS spike?


The authors rightly point out in the conclusion that transparency and quality control are necessary aspects of any biological roll out into humans. They penned an extremely well-researched and articulated paper based on the potential devastating effects of codon optimization of the spike protein currently being injected into everyone, but that they are not able to publish it. For some reason. The ‘reasons’ being given to them sound very familiar to the ‘reason’ that Peter and I received in the context of our Myocarditis paper that is still in limbo.

Public and transparent quality control of these often-mandated injections are required. This should include sequence verification and quality control of the various lots and evidence of the proteins these mRNA express in patients.

Another very interesting topic of concern raised in this paper is the following: there is a superantigen residing in the SARS-nCoV-2 spike protein. Was it put there? Before I proceed into this Substack further, I highly recommend reading Kevin, Peter and Anthony’s paper and if you’re interested, Tamara Ugolini interviewed Kevin on this subject matter recently and you can watch that here.